The Study To assess The Effectiveness Of Homoeopathic Medicine Viburnum Opulus In Cases Of Pelvic Inflammatory Disease In Comparison To Individualized Medicines.

Phase 3

Not yet recruiting

Lead Sponsor: Dr MPK Homoeopathic Medical College Hospital and Research Centre

Brief Summary: A Study is A randomized controlled trial to assess the effectiveness of individualized medicine as compare individualized medicine *Viburnum opulus* as an add on therapy in the management of pelvic inflammatory disease. Study will be done on 70 patients carried out for 12 months. The out come assessment will be done on the basis of Changes in VAS score will be noted for every symptom and WHO QOL-BREF before and after treatment.

Recruitment & Eligibility

Inclusion Criteria

Previously diagnosed cases of PID seeking homoeopathic treatment or newly diagnosed.
As per sign & symptoms and CDC (adopted from DC Duttaâ€™s textbook of gynecology 7th edition) Patients with 3-4 confirmatory sign and symptoms given below shall be enrolled for the study irrespective of the diagnosis based on investigations- a.
Pelvic pain or lower abdomen pain or back pain.
Abnormal & heavy Vaginal discharge (purulent and or copious) c.
Offensive vaginal odor.
Cervical motion tenderness.
Lower abdomen tenderness.
Adnexal tenderness.
Pruritis vulva.
Dyspareunia.
Irregular vaginal bleeding.
Fever Diagnostic criteria- 1.symptoms as mentioned above.
2.USG/ laboratory investigation done if required in case of unclear symptoms given above.

Exclusion Criteria

Cases which required any emergency treatment.
Patient pursuing other treatment and were not willing to leave it.
Pregnant women and lactating mothers will not be included in the study.
5.Cases with multi systemic illness will be excluded from the study and cases with advance pathology & malignancy.

Primary Outcome Measures

Name	Time	Method
Changes in VAS score will be noted for every symptom before, during and after treatment and shall be analysed to assess the efficacy of treatment given.	Changes in VAS score will be noted for every symptom before, during and after treatment and shall be analysed to assess the efficacy of treatment given at 12 month.

Secondary Outcome Measures

Name	Time	Method
Changes in WHO QOL-BREF scale will be noted for before and after treatment and shall be analysed to assess the efficacy of treatment given .	1year

Locations (1): Dr Girendra Pal Homoeopathic Hospital and Research Centre
🇮🇳
Jaipur, RAJASTHAN, India
Dr Girendra Pal Homoeopathic Hospital and Research Centre
🇮🇳Jaipur, RAJASTHAN, India
Dr Ankita Srivastava
Principal investigator
8503039881
ankitasri229@gmail.com